Bundibugyo Virus Disease Outbreak in Democratic Republic of Congo
The Centers for Disease Control and Prevention (CDC) has issued a Level 3 - Avoid Nonessential Travel alert for Haut-Uélé and Tshopo provinces in the Democratic Republic of the Congo due to an ongoing outbreak of Bundibugyo virus disease (BVD).
Outbreak Overview
Bundibugyo virus is one of four known ebolaviruses capable of causing human disease. This particular outbreak represents a significant public health concern in the affected provinces. The virus is transmitted to humans through contact with blood or body fluids of infected persons or animals, with person-to-person transmission occurring through direct contact with bodily fluids or tissues of infected individuals.
Risk Factors for Travelers
Travelers to affected provinces face heightened risk of exposure, particularly those who:
- Have direct contact with infected individuals or their bodily fluids
- Work in healthcare settings without proper infection control
- Have contact with animals (bushmeat hunting or handling)
- Participate in burial ceremonies involving traditional practices
Recommended Precautions
Travelers who must visit other areas of DRC should:
- Maintain strict hygiene practices
- Avoid contact with blood, body fluids, and tissues of infected persons
- Practice careful hand hygiene
- Use appropriate personal protective equipment in healthcare settings
- Avoid contact with animals, particularly fruit bats and primates
- Seek immediate medical attention if symptoms develop during or after travel
Clinical Awareness
Symptoms may include fever, severe headache, muscle pain, weakness, and gastrointestinal symptoms, appearing 2-21 days after exposure. No specific antiviral treatment exists; management is supportive.
Pharmacist's Note: While no prophylactic medications prevent Bundibugyo virus infection, travelers should ensure routine vaccinations (yellow fever, routine immunizations) are current before visiting DRC. Those with chronic conditions requiring medications should maintain adequate supply and consult healthcare providers about travel feasibility. Upon return, seek medical evaluation immediately if fever or symptoms develop within three weeks, informing providers of travel history and potential exposure.
Resources
Consult CDC Travel Health Notices and your healthcare provider before traveling to affected regions.